Procept Biorobotics Corp reports results for the quarter ended March 31 - Earnings Summary

PROCEPT BioRobotics

24/04/2025 14:33

Procept Biorobotics Corp PRCT.OQ reported a quarterly adjusted loss of 45 cents​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of -51 cents.  The mean expectation of ten analysts for the quarter was for a loss of 49 cents per share. Wall Street expected results to range from -51 cents to -47 cents per share.

Revenue rose 55.3% to $69.16 million from a year ago; analysts expected $65.68 million.

Procept Biorobotics Corp's reported EPS for the quarter was a loss of 45 cents​.

The company reported a quarterly loss of $24.74 million.

Procept Biorobotics Corp shares had fallen by 4.4% this quarter and lost 30.8% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had fallen by about 38.3% in the last three months.​

In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for Procept Biorobotics Corp is $95.00

This summary was machine generated from LSEG data April 24 at 01:33 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Mar. 31 2025
-0.49
-0.45
Beat
Dec. 31 2024
-0.33
-0.35
Missed
Sep. 30 2024
-0.49
-0.40
Beat
Jun. 30 2024
-0.52
-0.50
Beat